Search by Drug Name or NDC
NDC 50090-1860-00 M-M-R II 1000; 12500; 1000 [TCID_50]/.5mL; [TCID_50]/.5mL; [TCID_50]/.5mL Details
M-M-R II 1000; 12500; 1000 [TCID_50]/.5mL; [TCID_50]/.5mL; [TCID_50]/.5mL
M-M-R II is a SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION in the VACCINE category. It is labeled and distributed by A-S Medication Solutions. The primary component is MEASLES VIRUS STRAIN ENDERS' ATTENUATED EDMONSTON LIVE ANTIGEN; MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN; RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN.
MedlinePlus Drug Summary
Why get vaccinated? MMR vaccine can prevent measles, mumps, and rubella. Measles (M)causes fever, cough, runny nose, and red, watery eyes, commonly followed by a rash that covers the whole body. It can lead to seizures (often associated with fever), ear infections, diarrhea, and pneumonia. Rarely, measles can cause brain damage or death. Mumps (M) causes fever, headache, muscle aches, tiredness, loss of appetite, and swollen and tender glands under the ears. It can lead to deafness, swelling of the brain and/or spinal cord covering, painful swelling of the testicles or ovaries, and, very rarely, death. Rubella (R) causes fever, sore throat, rash, headache, and eye irritation. It can cause arthritis in up to half of teenage and adult women. If a person gets rubella while they ares pregnant, they could have a miscarriage or the baby could be born with serious birth defects. Most people who are vaccinated with MMR will be protected for life. Vaccines and high rates of vaccination have made these diseases much less common in the United States.
Related Packages: 50090-1860-00Last Updated: 11/30/2022
MedLinePlus Full Drug Details: MMR Vaccine (Measles, Mumps, and Rubella)
Product Information
NDC | 50090-1860 |
---|---|
Product ID | 50090-1860_209cfa40-41ef-418c-bd40-f9ca28ce555b |
Associated GPIs | 17109903102100 |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | M-M-R II |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | measles, mumps, and rubella virus vaccine live |
Product Type | VACCINE |
Dosage Form | INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION |
Route | SUBCUTANEOUS |
Active Ingredient Strength | 1000; 12500; 1000 |
Active Ingredient Units | [TCID_50]/.5mL; [TCID_50]/.5mL; [TCID_50]/.5mL |
Substance Name | MEASLES VIRUS STRAIN ENDERS' ATTENUATED EDMONSTON LIVE ANTIGEN; MUMPS VIRUS STRAIN B LEVEL JERYL LYNN LIVE ANTIGEN; RUBELLA VIRUS STRAIN WISTAR RA 27/3 LIVE ANTIGEN |
Labeler Name | A-S Medication Solutions |
Pharmaceutical Class | Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Actively Acquired Immunity [PE], Live Attenuated Measles Virus Vaccine [EPC], Live Attenuated Mumps Virus Vaccine [EPC], Live Attenuated Rubella Virus Vaccine [EPC], Measles Vaccine [CS], M |
DEA Schedule | n/a |
Marketing Category | BLA |
Application Number | BLA101069 |
Listing Certified Through | 2024-12-31 |
Package
NDC 50090-1860-00 (50090186000)
NDC Package Code | 50090-1860-0 |
---|---|
Billing NDC | 50090186000 |
Package | 10 VIAL, SINGLE-DOSE in 1 CARTON (50090-1860-0) / .5 mL in 1 VIAL, SINGLE-DOSE (50090-1860-9) |
Marketing Start Date | 1971-04-21 |
NDC Exclude Flag | N |
Pricing Information | N/A |